VKO5B826

BCL2L13 Knockout cell line ( Hela)

This BCL2L13 KO cell line is made by CRISPR/Cas9 technology. The target gene is full allelic knockout. It is available in stock, and the lead time is 2-3 weeks. Please feel free to contact us for more cell information and order placing.

Images

Key facts

Product name: BCL2L13 Knockout cell line ( Hela)
Catalog No.: VKO5B826
Form: Ship in dry ice
Note: FOR RESEARCH USE ONLY

Product size:

1*10^6 cells/vial

US$ 2200

US$ 3000

(excl. sales tax)

Lead time: 6-10 weeks

Get a quote

Key facts

Product name

BCL2L13 Knockout cell line ( Hela)

Catalog No.

VKO5B826

Shipping and Storage

Ship in dry ice, store in liquid nitrogen vapor phase

Properties

Host cell line

Human Cervical Carcinoma Cell Line (HeLa)

Target

BCL2L13

Application

CRISPR gene knockout

Method

RNP

Form

Mono-clonal

Quality control

PCR

Sanger Sequencing

Cell culture

Biosafety level

Adherent/suspension

Adherent

Morphology

Epithelial-like

Culture medium

MEM+10% FBS

Freezing medium

50% MEM+40% FBS+10% DMSO

Downloads

Datasheet

Safety datasheet

Protocol

For further support, please contact us.

*Publications utilizing this product should include the following acknowledgment: "The BCL2L13 Knockout cell line ( Hela) (Cat. No. VKO5B826) was obtained from Vitro Biotech, Inc."